Exact Sciences (EXAS) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access EXAS Annual Balance Sheets →
Reviewing balance sheet data across recent quarters allows users to assess how Exact Sciences manages assets, liabilities, and equity through different cycles.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Sep 30 2025) (Jun 30 2025) (Mar 31 2025) (Dec 31 2024)
Assets
Cash & cash equivalent956.00
Marketable Securities, Current SH8.72
Cash & Short-term Investments963.00
Accounts receivable298.65
Inventories166.20
Prepaid Expense And Other Assets Current126.28
Total Current Assets1,555.85
Equipment/Property/Plant Net708.66
Goodwill net2,368.05
Intangible Assets919.93
Other Assets, Noncurrent308.14
Total Assets5,860.63
Liabilities
Accounts Payable, Current AC175.87
Accrued Liabilities, Current AC416.47
Convertible Notes Payable, Current NO0.00
Other Liabilities, Current15.22
Total Current Liabilities641.15
Convertible Notes Payable, Noncurrent LO2,327.18
Total Long-term Debt2,327.18
Other liabilities, Noncurrent491.25
Accrued Interest33.59
Total Liabilities3,459.58
Stockholders' Equity
Common Stock Value1.91
Additional Paid In Capital Common Stock7,102.77
Retained Earnings / Accumulated Deficit-4,705.98
Other Equity2.36
Common Stockholder's Equity2,401.05
Total Stockholder's Equity2,401.05
Liabilities & Stockholder's Equity5,860.63
4 historic quarters locked

Sign in to unlock the full Exact Sciences balance sheet history.

About Exact Sciences Corp Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001124140-25-000091

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.